SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
ADVANCES IN TB AND CRYPTOCOCCAL MENINGITIS TREATMENT AND PREVENTION
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
EFFECT OF TB SCREENING AND RETENTION INTERVENTIONS ON EARLY ART MORTALITY IN BOTSWANA (ABSTRACT
31)
Andrew Francis Auld
U.S. Centers for Disease Control and Prevention (CDC), Dulles, VA, USA
A CLUSTER-RANDOMIZED TRIAL OF SYMPTOM VS TST SCREENING TO IMPROVE CHILD IPT UPTAKE (ABSTRACT
32)
Nicole Salazar-Austin
Johns Hopkins University School of Medicine, Baltimore, MD, USA
SAFETY AND EFFICACY OF DOLUTEGRAVIR-BASED ART IN TB/HIV COINFECTED ADULTS AT WEEK 24 (ABSTRACT
33)
Kelly Dooley
Johns Hopkins University, Baltimore, MD, USA
PHARMACOKINETICS OF BICTEGRAVIR ADMINISTERED TWICE DAILY IN COMBINATION WITH RIFAMPIN (ABSTRACT
34)
Joseph M. Custodio
Gilead Science, Foster city, CA, USA
HIGHER HIGH DOSE FLUCONAZOLE FOR THE TREATMENT OF CRYPTOCOCCAL MENINGITIS (ABSTRACT
35)
Wadzanai Samaneka
Parirenyatwa Clinical Research Site, Harare, Zimbabwe
ADJUNCTIVE SERTRALINE IN HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS (ABSTRACT
36)
Joshua Rhein
University of Minnesota, Minneapolis, MN, USA
ONE MONTH OF RIFAPENTINE/ISONIAZID TO PREVENT TB IN PEOPLE WITH HIV: BRIEF-TB/A5279 (ABSTRACT
37LB)
Richard E. Chaisson
Johns Hopkins University, Baltimore, MD, USA
URINE-BASED SCREENING FOR TUBERCULOSIS: A RANDOMIZED TRIAL IN HIV-POSITIVE INPATIENTS (ABSTRACT
38LB)
Ankur Gupta-Wright
London School of Hygiene & Tropical Medicine, London, United Kingdom
A RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE RIFAMPIN FOR PULMONARY TUBERCULOSIS (ABSTRACT
39LB)
Gustavo E Velásquez
Brigham and Women's Hospital, Boston, MA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
